Schonhaut DR, McMillan CT, Spina S, Dickerson BC, Siderowf A, Devous MD, Tsai R, Winer J, Russell DS, Litvan I et al..  2017.   F-flortaucipir tau positron emission tomography distinguishes established progressive supranuclear palsy from controls and Parkinson disease: A multicenter study.. Ann Neurol. 82(4):622-634.

Ahmed AO, Murphy CF, Latoussakis V, McGovern KE, English J, Bloch A, Anthony DT, Savitz AJ.  2016.  An examination of neurocognition and symptoms as predictors of post-hospital community tenure in treatment resistant schizophrenia.. Psychiatry Res. 236:47-52.

Maurer CW, LaFaver K, Ameli R, Epstein SA, Hallett M, Horovitz SG.  2016.  Impaired self-agency in functional movement disorders: A resting-state fMRI study.. Neurology. 87(6):564-70.

Rosell DR, Zaluda LC, McClure MM, M Perez-Rodriguez M, K Strike S, Barch DM, Harvey PD, Girgis RR, Hazlett EA, Mailman RB et al..  2015.  Effects of the D1 dopamine receptor agonist dihydrexidine (DAR-0100A) on working memory in schizotypal personality disorder.. Neuropsychopharmacology. 40(2):446-53.

Decker JHugo, Figner B, Steinglass JE.  2015.  On Weight and Waiting: Delay Discounting in Anorexia Nervosa Pretreatment and Posttreatment.. Biol Psychiatry. 78(9):606-14.

Baker LM, Paul RH, Heaps JM, Westerhaus E, Chang JYoon, Williams S, Brier MR, Plax K, Ances BM.  2014.  Impact of human immunodeficiency virus on neurocognition and risky behaviors in young adults.. J Neurovirol. 20(5):466-73.

Massimo L, Libon DJ, Chandrasekaran K, Dreyfuss M, McMillan CT, Rascovsky K, Boller A, Grossman M.  2013.  Self-appraisal in behavioural variant frontotemporal degeneration.. J Neurol Neurosurg Psychiatry. 84(2):148-53.

Butler T, Imperato-McGinley J, Pan H, Voyer D, Cunningham-Bussel AChristine, Chang L, Zhu Y-S, Cordero JJ, Stern E, Silbersweig D.  2007.  Sex specificity of ventral anterior cingulate cortex suppression during a cognitive task.. Hum Brain Mapp. 28(11):1206-12.